These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1395 related articles for article (PubMed ID: 16115318)

  • 1. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread.
    Vincent MJ; Bergeron E; Benjannet S; Erickson BR; Rollin PE; Ksiazek TG; Seidah NG; Nichol ST
    Virol J; 2005 Aug; 2():69. PubMed ID: 16115318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe acute respiratory syndrome coronavirus entry as a target of antiviral therapies.
    Kuhn JH; Li W; Radoshitzky SR; Choe H; Farzan M
    Antivir Ther; 2007; 12(4 Pt B):639-50. PubMed ID: 17944271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.
    Matsuyama S; Nagata N; Shirato K; Kawase M; Takeda M; Taguchi F
    J Virol; 2010 Dec; 84(24):12658-64. PubMed ID: 20926566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction.
    Ho TY; Wu SL; Chen JC; Li CC; Hsiang CY
    Antiviral Res; 2007 May; 74(2):92-101. PubMed ID: 16730806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor.
    Han DP; Penn-Nicholson A; Cho MW
    Virology; 2006 Jun; 350(1):15-25. PubMed ID: 16510163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of cholesterol-rich membrane microdomains in the interaction of the S protein of SARS-coronavirus with the cellular receptor angiotensin-converting enzyme 2.
    Glende J; Schwegmann-Wessels C; Al-Falah M; Pfefferle S; Qu X; Deng H; Drosten C; Naim HY; Herrler G
    Virology; 2008 Nov; 381(2):215-21. PubMed ID: 18814896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone alters late endosomes and inhibits SARS coronavirus infection at a post-endosomal level.
    Stadler K; Ha HR; Ciminale V; Spirli C; Saletti G; Schiavon M; Bruttomesso D; Bigler L; Follath F; Pettenazzo A; Baritussio A
    Am J Respir Cell Mol Biol; 2008 Aug; 39(2):142-9. PubMed ID: 18314540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spike protein of SARS-CoV--a target for vaccine and therapeutic development.
    Du L; He Y; Zhou Y; Liu S; Zheng BJ; Jiang S
    Nat Rev Microbiol; 2009 Mar; 7(3):226-36. PubMed ID: 19198616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins.
    Wang SF; Tseng SP; Yen CH; Yang JY; Tsao CH; Shen CW; Chen KH; Liu FT; Liu WT; Chen YM; Huang JC
    Biochem Biophys Res Commun; 2014 Aug; 451(2):208-14. PubMed ID: 25073113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.
    Pinto D; Park YJ; Beltramello M; Walls AC; Tortorici MA; Bianchi S; Jaconi S; Culap K; Zatta F; De Marco A; Peter A; Guarino B; Spreafico R; Cameroni E; Case JB; Chen RE; Havenar-Daughton C; Snell G; Telenti A; Virgin HW; Lanzavecchia A; Diamond MS; Fink K; Veesler D; Corti D
    Nature; 2020 Jul; 583(7815):290-295. PubMed ID: 32422645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine.
    Keyaerts E; Vijgen L; Maes P; Neyts J; Van Ranst M
    Biochem Biophys Res Commun; 2004 Oct; 323(1):264-8. PubMed ID: 15351731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein.
    Fukushi S; Mizutani T; Saijo M; Matsuyama S; Miyajima N; Taguchi F; Itamura S; Kurane I; Morikawa S
    J Gen Virol; 2005 Aug; 86(Pt 8):2269-2274. PubMed ID: 16033974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway.
    Wang H; Yang P; Liu K; Guo F; Zhang Y; Zhang G; Jiang C
    Cell Res; 2008 Feb; 18(2):290-301. PubMed ID: 18227861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63.
    Glowacka I; Bertram S; Herzog P; Pfefferle S; Steffen I; Muench MO; Simmons G; Hofmann H; Kuri T; Weber F; Eichler J; Drosten C; Pöhlmann S
    J Virol; 2010 Jan; 84(2):1198-205. PubMed ID: 19864379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor.
    Ge XY; Li JL; Yang XL; Chmura AA; Zhu G; Epstein JH; Mazet JK; Hu B; Zhang W; Peng C; Zhang YJ; Luo CM; Tan B; Wang N; Zhu Y; Crameri G; Zhang SY; Wang LF; Daszak P; Shi ZL
    Nature; 2013 Nov; 503(7477):535-8. PubMed ID: 24172901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus.
    Nagata N; Iwata N; Hasegawa H; Fukushi S; Yokoyama M; Harashima A; Sato Y; Saijo M; Morikawa S; Sata T
    J Virol; 2007 Feb; 81(4):1848-57. PubMed ID: 17151094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics.
    Kao RY; Tsui WH; Lee TS; Tanner JA; Watt RM; Huang JD; Hu L; Chen G; Chen Z; Zhang L; He T; Chan KH; Tse H; To AP; Ng LW; Wong BC; Tsoi HW; Yang D; Ho DD; Yuen KY
    Chem Biol; 2004 Sep; 11(9):1293-9. PubMed ID: 15380189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections.
    Li F
    J Virol; 2008 Jul; 82(14):6984-91. PubMed ID: 18448527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Yao X; Ye F; Zhang M; Cui C; Huang B; Niu P; Liu X; Zhao L; Dong E; Song C; Zhan S; Lu R; Li H; Tan W; Liu D
    Clin Infect Dis; 2020 Jul; 71(15):732-739. PubMed ID: 32150618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A convenient cell fusion assay for the study of SARS-CoV entry and inhibition.
    Sha Y; Wu Y; Cao Z; Xu X; Wu W; Jiang D; Mao X; Liu H; Zhu Y; Gong R; Li W
    IUBMB Life; 2006 Aug; 58(8):480-6. PubMed ID: 16916786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.